share_log

Amalgamated Bank Sells 979 Shares of GMS Inc. (NYSE:GMS)

Amalgamated Bank Sells 979 Shares of GMS Inc. (NYSE:GMS)

合并银行出售GMS Inc.(纽约证券交易所代码:GMS)979股
Defense World ·  2022/09/30 04:11

Amalgamated Bank decreased its holdings in GMS Inc. (NYSE:GMS – Get Rating) by 4.8% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,308 shares of the company's stock after selling 979 shares during the period. Amalgamated Bank's holdings in GMS were worth $961,000 as of its most recent SEC filing.

据合并银行最近向美国证券交易委员会提交的13F文件显示,今年第一季度该行在GMS Inc.的持股减持了4.8%。该机构投资者在此期间出售了979股后,持有该公司19,308股股票。截至最近的美国证券交易委员会申报文件,合并银行持有的GMS股份价值96.1万美元。

Other institutional investors also recently made changes to their positions in the company. New York State Common Retirement Fund boosted its stake in shares of GMS by 37.6% in the 1st quarter. New York State Common Retirement Fund now owns 43,080 shares of the company's stock valued at $2,144,000 after purchasing an additional 11,780 shares in the last quarter. Summit Global Investments purchased a new stake in shares of GMS in the 1st quarter valued at $1,090,000. Swiss National Bank boosted its stake in shares of GMS by 7.7% in the 1st quarter. Swiss National Bank now owns 91,800 shares of the company's stock valued at $4,569,000 after purchasing an additional 6,600 shares in the last quarter. Reinhart Partners Inc. boosted its stake in shares of GMS by 4.4% in the 1st quarter. Reinhart Partners Inc. now owns 300,317 shares of the company's stock valued at $14,947,000 after purchasing an additional 12,651 shares in the last quarter. Finally, Jackson Creek Investment Advisors LLC purchased a new stake in shares of GMS in the 1st quarter valued at $1,001,000. Hedge funds and other institutional investors own 98.94% of the company's stock.

其他机构投资者最近也对他们在该公司的头寸进行了调整。纽约州共同退休基金在第一季度增持了37.6%的GMS股票。纽约州共同退休基金现在拥有43,080股该公司股票,价值2,144,000美元,上个季度又购买了11,780股。Summit Global Investments在第一季度购买了GMS的新股,价值1090,000美元。瑞士国家银行在第一季度增持了7.7%的GMS股票。瑞士国家银行现在拥有91,800股该公司股票,价值456.9万美元,上个季度又购买了6600股。莱因哈特合伙公司(Reinhart Partners Inc.)在第一季度增持了GMS 4.4%的股份。莱因哈特合伙公司目前持有300,317股该公司股票,价值14,947,000美元,上个季度又购买了12,651股。最后,Jackson Creek Investment Advisors LLC在第一季度购买了价值1001,000美元的GMS新股。对冲基金和其他机构投资者持有该公司98.94%的股票。

Get
到达
GMS
转基因食品
alerts:
警报:

GMS Stock Down 2.0 %

GMS股价下跌2.0%

Shares of GMS stock opened at $39.90 on Friday. The company has a debt-to-equity ratio of 1.05, a current ratio of 2.30 and a quick ratio of 1.43. The company has a 50-day moving average of $48.44 and a 200 day moving average of $48.12. The firm has a market cap of $1.69 billion, a price-to-earnings ratio of 5.77 and a beta of 1.85. GMS Inc. has a 1 year low of $36.10 and a 1 year high of $61.79.

GMS股票上周五开盘报39.90美元。该公司的债务权益比为1.05,流动比率为2.30,速动比率为1.43。该公司的50日移动均线切入位在48.44美元,200日移动均线切入位在48.12美元。该公司的市值为16.9亿美元,市盈率为5.77倍,贝塔系数为1.85。GMS Inc.的一年低点为36.10美元,一年高位为61.79美元。

GMS (NYSE:GMS – Get Rating) last released its quarterly earnings data on Thursday, September 1st. The company reported $2.43 earnings per share for the quarter, beating analysts' consensus estimates of $2.25 by $0.18. The business had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.35 billion. GMS had a net margin of 6.09% and a return on equity of 34.71%. GMS's revenue was up 30.5% compared to the same quarter last year. During the same period last year, the business earned $1.67 EPS. As a group, sell-side analysts anticipate that GMS Inc. will post 7.9 earnings per share for the current fiscal year.
通用汽车(纽约证券交易所代码:GMS-GET Rating)最近一次发布季度收益数据是在9月1日星期四。该公司公布本季度每股收益为2.43美元,比分析师普遍预期的2.25美元高出0.18美元。该业务本季度营收为13.6亿美元,而分析师预期为13.5亿美元。通用汽车的净利润率为6.09%,股本回报率为34.71%。与去年同期相比,通用汽车的收入增长了30.5%。去年同期,该业务每股收益为1.67美元。卖方分析师预计,GMS Inc.本财年每股收益将达到7.9美元。

Analyst Upgrades and Downgrades

分析师升级和下调评级

GMS has been the subject of a number of research reports. Raymond James reaffirmed an "outperform" rating and issued a $70.00 price objective (down previously from $72.00) on shares of GMS in a research note on Friday, June 24th. StockNews.com raised shares of GMS from a "buy" rating to a "strong-buy" rating in a research report on Monday, June 27th. Royal Bank of Canada cut shares of GMS from an "outperform" rating to a "sector perform" rating and dropped their price target for the company from $73.00 to $46.00 in a research report on Wednesday, June 22nd. Robert W. Baird dropped their price target on shares of GMS from $68.00 to $55.00 and set an "outperform" rating for the company in a research report on Friday, June 24th. Finally, Truist Financial cut shares of GMS from a "buy" rating to a "hold" rating and dropped their price target for the company from $50.00 to $46.00 in a research report on Wednesday, September 7th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $56.67.

转基因生物一直是许多研究报告的主题。雷蒙德·詹姆斯(Raymond James)在6月24日(星期五)的一份研究报告中重申了对GMS的“跑赢大盘”评级,并发布了GMS股票的70.00美元目标价(低于之前的72.00美元)。在6月27日周一的一份研究报告中,StockNews.com将GMS的股票评级从“买入”上调至“强势买入”。在6月22日星期三的一份研究报告中,加拿大皇家银行将GMS的股票评级从“跑赢大盘”下调至“行业表现”,并将该公司的目标价从73.00美元下调至46.00美元。罗伯特·W·贝尔德在6月24日星期五的一份研究报告中将GMS的股票目标价从68.00美元下调至55.00美元,并为该公司设定了“跑赢大盘”的评级。最后,Truist Financial在9月7日星期三的一份研究报告中将GMS的股票评级从买入下调至持有,并将该公司的目标价从50.00美元下调至46.00美元。三位分析师对该股的评级为持有,三位分析师给出了买入评级,一位分析师给出了强烈的买入评级。根据MarketBeat的数据,该股目前的平均评级为“中等买入”,平均目标价为56.67美元。

Insider Buying and Selling at GMS

GMS的内部买入和卖出

In other GMS news, VP Craig D. Apolinsky sold 6,324 shares of the firm's stock in a transaction dated Tuesday, September 27th. The shares were sold at an average price of $39.07, for a total transaction of $247,078.68. Following the completion of the sale, the vice president now directly owns 9,870 shares in the company, valued at approximately $385,620.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by company insiders.

在GMS的其他新闻中,副总裁克雷格·D·阿波林斯基在日期为9月27日(星期二)的交易中出售了6,324股该公司股票。这些股票以39.07美元的平均价格出售,总成交额为247,078.68美元。出售完成后,总裁副总经理现在直接持有该公司9870股股份,价值约385,620.90美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过美国证券交易委员会网站。1.60%的股份由公司内部人士持有。

GMS Company Profile

GMS公司简介

(Get Rating)

(获取评级)

GMS Inc distributes wallboard, ceilings, steel framing and complementary construction products in the United States and Canada. The company offers ceilings products, including suspended mineral fibers, soft fibers, and metal ceiling systems primarily used in offices, hotels, hospitals, retail facilities, schools, and various other commercial and institutional buildings.

GMS Inc.在美国和加拿大分销墙板、天花板、钢框架和互补建筑产品。该公司提供天花板产品,包括悬浮矿物纤维、软纤维和金属天花板系统,主要用于办公室、酒店、医院、零售设施、学校和各种其他商业和机构建筑。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on GMS (GMS)
  • Humana Proves Vertically Integrated Healthcare Works
  • 2 Casino Stocks Worth Taking a Look At
  • This Small-Cap Healthcare Name Is Outperforming Its Index
  • What Cintas Can Teach Investors About This Bear Market?
  • Blackberry Stock Declines As Results Come In Lukewarm Once Again
  • 免费获取StockNews.com关于GMS(GMS)的研究报告
  • Humana证明垂直整合的医疗保健工作
  • 值得一看的2只赌场股票
  • 这家小盘股医疗保健公司的表现好于其指数
  • 关于这个熊市,Cintas能教给投资者什么?
  • 黑莓股价下跌,业绩再次不温不火

Want to see what other hedge funds are holding GMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GMS Inc. (NYSE:GMS – Get Rating).

想看看其他对冲基金持有GMS的情况吗?访问HoldingsChannel.com获取GMS Inc.(纽约证券交易所代码:GMS-GET Rating)的最新13F备案和内幕交易信息。

Receive News & Ratings for GMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMS and related companies with MarketBeat.com's FREE daily email newsletter.

接受GMS日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对GMS和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发